Contact Lens Spectrum

References

February 2020

Document #291

(p. 12) Research Review – Hot Topics in Scleral Contact Lens
By Andrew D. Pucker, OD, PhD

  1. van der Worp E, Barnett M, Johns L. Scleral lenses: History & future. Cont Lens Anterior Eye. 2018 Jun;41:243-244.
  2. Harthan J, Shorter E, Nau C, et al. Scleral lens fitting and assessment strategies. Cont Lens Anterior Eye. 2019 Feb;42:9-14.
  3. Nau CB, Harthan J, Shorter E, et al. Demographic Characteristics and Prescribing Patterns of Scleral Lens Fitters: The SCOPE Study. Eye Contact Lens. 2018 Sep;44 Suppl 1:S265-S272.
  4. Pucker AD, Bickle KM, Jones-Jordan LA, et al. Assessment of a practitioner's perception of scleral contact lens complications. Cont Lens Anterior Eye. 2019 Feb;42:15-19.
  5. Bickle KM, Jones-Jordan LA, Kuhn J, et al. Initial Scleral Contact Lens Wearing Experience. Poster Presented at the 2019 Global Specialty Lens Symposium, Las Vegas.
  6. Schornack M, Harthan J, Barr JT, Shorter E, Nau A, Nau CB. Complications of Scleral Lens Wear. Poster presented during ARVO 2016; Abstract 1467.
  7. Michaud L, van der Worp E, Brazeau D, Warde R, Giasson CJ. Predicting estimates of oxygen transmissibility for scleral lenses. Cont Lens Anterior Eye. 2012 Dec;35:266-271.
  8. Kim YH, Tan B, Lin MC, Radke CJ. Central Corneal Edema with Scleral-Lens Wear. Curr Eye Res. 2018 Nov;43:1305-1315.
  9. Postnikoff C, Laurent J, Pucker AD, Nichols JJ. Investigation of Leukocytes in the Post-Lens Tear Film of Scleral Contact Lens Wearers. Invest Ophthalmol Vis Sci. 2019 Jan;60:226-233.
  10. McKinney A, Miller WL, Leach N, Polizzi C, van der Worp E, Bergmanson J. The Cause of Midday Visual Fogging in Scleral Gas Permeable Lens Wearers. Invest Ophthalmol Vis Sci. 2013 Jun;54:5483.
  11. Skidmore KV, Walker MK, Marsack JD, Bergmanson JPG, Miller WL. A measure of tear inflow in habitual scleral lens wearers with and without midday fogging. Cont Lens Anterior Eye. 2019 Feb;42:36-42.
  12. Walker MK, Bergmanson JP, Miller WL, Marsack JD, Johnson LA. Complications and fitting challenges associated with scleral contact lenses: A review. Cont Lens Anterior Eye. 2016 Apr;39:88-96.
  13. Paugh JR, Chen E, Heinrich C, et al. Silicone Hydrogel and Rigid Gas-Permeable Scleral Lens Tear Exchange. Eye Contact Lens. 2018 Mar;44:97-101.
  14. Consejo A, Llorens-Quintana C, Bartuzel MM, Iskander DR, Rozema JJ. Rotation asymmetry of the human sclera. Acta Ophthalmol. 2019 Mar;97:e266-e270.
  15. Zimmerman AB, Marks A. Microbial keratitis secondary to unintended poor compliance with scleral gas-permeable contact lenses. Eye Contact Lens. 2014;40:e1-e4.

(p. 18) Hybrid How-To – Can Multifocal Hybrids Slow Myopia Progression?
By Stephanie Ramdass, OD, MS, MBA

  1. Wolffsohn JS, Kollbaum PS, Bernsten DA, et al. IMI – Clinical Myopia Control Trials and Instrumentation Report. Invest Ophthalmol Vis Sci. 2019 Feb 28;60:M132-M160.
  2. Chung K, Mohidin N, O’Leary DJ. Undercorrection of myopia enhances rather than inhibits myopia progression. Vision Res. 2002 Oct;42:2555-2559.
  3. Alder D, Millodot M. The possible effect of undercorrection on myopic progression in children. Clin Exp Optom. 2006 Sep;89:315-321.
  4. Wildsoet CF, Chia A, Cho P, et al. IMI – Interventions for Controlling Myopia Onset and Progression Report. Invest Ophthalmol Vis Sci. 2019 Feb;60:M106-M131.

(p. 19) Myopia Matters – Overcoming “So What, It’s Only Myopia” Syndrome
By Gary Gerber, OD

  1. Saw SM, Gazzard G, Shih-Yen EC, Chua WH. Myopia and associated pathological complications. Ophthalmic Physiol Opt. 2005 Sep;25:381-391.

(p. 44) Pediatric and Teen CL Care – Contact Lens Management of Peters Anomaly
By Melanie Frogozo, OD

  1. Zaidman GW, Flanagan JK, Furey CC. Long-term visual prognosis in children after corneal transplant surgery for Peters anomaly type I. Am J Ophthalmol. 2007 Jul;144:104-108.
  2. Bhandari R, Ferri S, Whittaker B, Liu M, Lazzaro DR. Peters anomaly: review of the literature. Cornea. 2011 Aug;30:939-944.
  3. Yang LL, Lambert SR, Drews-Botsch C, Stulting RD. Long-term visual outcome of penetrating keratoplasty in infants and children with Peters anomaly. J AAPOS. 2009 Apr;13:175-180.
  4. Zaidman GW, Rabinowitz Y, Forstot SL. Optical iridectomy for corneal opacities in Peter's anomaly. J Cataract Refract Surg. 1998 May;24:719-722.

(p. 48) Reader and Industry Forum – The Rise of Hypochlorous Acid in Eye Care
By Cristina Tanasescu & Etty Bitton, OD, MSC

  1. Lemp MA, Nichols KK. Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment. Ocul Surf. 2009 Apr;7(2 Suppl):S1-S14.
  2. Amescua G, Akpek EK, Farid M, et al. Blepharitis Preferred Practice Pattern®. Ophthalmology. 2019 Jan;126:P56-P93.
  3. American Optometric Association. Care for the patient with blepharitis. Available at https://www.aoa.org/documents/optometrists/QRG-10A.pdf . Accessed Sept. 2, 2019.
  4. Bernardes T, Bonfioli AA. Blepharitis. Semin Ophthalmol. 2010 May;25:79-83.
  5. Kanski J, Bowling B. Clinical ophthalmology: a systematic approach. 7th edition. Elsevier Health Sciences; 2011:34.
  6. Benitez-del-Castillo JM. How to promote and preserve eyelid health. Clin Ophthalmol. 2012;6:1689-1698.
  7. Chen X, Chunyan G, Kong J. Oxidative stress in neurodegenerative diseases. Neural Regen Res. 2012 Feb 15;7:376-385.
  8. Wang L, Bassiri M, Najafi R. Hypochlorous acid as a potential wound care agent: part I. Stabilized hypochlorous acid: a component of the inorganic armamentarium of innate immunity. J Burns Wounds. 2007 Apr 11;6:e5.
  9. Del Rosso JQ, Bhatia N. Status Report on Topical Hypochlorous Acid: Clinical Relevance of Specific Formulations, Potential Modes of Action, and Study Outcomes. J Clin Aesthet Dermatol. 2018 Nov;11:36-39.
  10. Najafi-Tagol K. “Open Your Eyes” to a New Way For Treating Conditions Associated With Blepharitis. 2014. Available at https://novabay.com/wp-content/uploads/2016/04/Eye-Institute-of-Marin-Open-your-Eyes-Newsletter.pdf . Accessed Sep. 2, 2019.
  11. Kramer A, Dissemond J, Kim S, et al. Consensus on Wound Antisepsis: Update 2018. Skin Pharmacol Physiol. 2018;31(1):28-58.
  12. Anagnostopoulos AG, Rong A, Miller D, et al. 0.01% Hypochlorous Acid as an Alternative Skin Antiseptic: An In Vitro Comparison. Dermatol Surg. 2018 Dec;44:1489-1493.
  13. Zhang, X, M VJ. Qu Y, et al. Dry Eye Management: Targeting the Ocular Surface Microenvironment. Int J Mol Sci.. 2017 Jun 29;18:E1398.
  14. Baudouin C, Messmer EM, Aragona P, et al. Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction. B J Ophthalmol. 2016 Mar;100: 300-306.
  15. Shin H, Price K, Albert L, Dodick J, Park L, Dominguez-Bello MG. Changes in the Eye Microbiota Associated with Contact Lens Wearing. MBio. 2016 Mar 22;7:e 00198.
  16. Zhang H, Zhao F, Hutchinson DS, et al. Conjunctival Microbiome Changes Associated With Soft Contact Lens and Orthokeratology Lens Wearing. Invest Ophthalmol Vis Sci. 2017 Jan 1;58:128-136.
  17. Boost M, Cho P, Wang Z. Disturbing the balance: effect of contact lens use on the ocular proteome and microbiome. Clin Exp Optom. 2017 Sep;100:459-472.
  18. Craig J, Nelson JD, Azar DT, et al. TFOS DEWS II Report Executive Summary. Ocul Surf. 2017 Oct;15:802-812.
  19. Nichols JJ, Willcox MD, Bron AJ, et al. The TFOS International Workshop on Contact Lens Discomfort: executive summary. Invest Ophthalmol Vis Sci. 2013 Oct 18;54:TFOS7-TFOS13.
  20. Romanowski EG, Stella NA, Yates KA, Brothers KM, Kowalski RP, Shanks RMQ. In Vitro Evaluation of a Hypochlorous Acid Hygiene Solution on Established Biofilms. Eye Contact Lens. 2018 Nov;44 Suppl 2:S187-S191.
  21. Ishihara M, Murakami K, Fukuda K, et al. Stability of Weakly Acidic Hypochlorous Acid Solution with Microbicidal Activity. Biocontrol Sci. 2017;22(4):223-227.

(p. 52) History of Contact Lenses – The Da Vinci Code Cracked
By Patrick J. Caroline & Craig W. Norman

  1. Heitz RF. The History of Contact Lenses, Volume One: Early Neutralizations of the Corneal Dioptric Power. Julius Hirschberg, Ostend, Belgium. 2003:21.